| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
James R Tobin is Director at GMED and has filed Form 4s across 2 companies. James R Tobin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Historically, James R Tobin's trades have earned a middling insider score of 60/100 across 13 rated trades. Over a 12-month horizon, 61.5% of those trades were profitable, with an average 12-month return of -12.7%.
James R Tobin has 45 Form 4 filings on record from January 2015 to September 2026, across 4 companies: Director at Globus Medical (GMED), 2015–2026; Director at TransMedics Group (TMDX), 2019–2026; Director at Lyra Therapeutics (LYRA), 2022–2025, and 1 more.
The 77 reported transactions were 31 open-market sales, 22 option or other derivative awards, 13 option exercises and 4 gifts, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 17 sales worth about $23.0M.
The largest open-market sale was 20,000 shares of TMDX at an average $159.33 on August 8, 2024, about $3.2M. Twelve months later TMDX was down 29%.
3 of the 6 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 3 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | GMED Globus Medical, Inc. | Director | Sale+OE | 30,000 | $74.58 | $2,237,502.00 | - | - | - | |
| Aug 8, 2024 | TMDX Transmedics Group, Inc. | Director | Sell | 20,000 | $159.33 | $3,186,536.00 | -10.4% | -46.6% | -29.3% | |
| May 3, 2024 | TMDX Transmedics Group, Inc. | Director | Sell10b5-1 | 12,025 | $125.05 | $1,503,686.50 | -5.9% | +18.4% | -29.7% | |
| May 1, 2024 | TMDX Transmedics Group, Inc. | Director | Sell10b5-1 | 15,040 | $106.43 | $1,600,632.76 | -6.8% | +17.7% | -23.1% | |
| Mar 1, 2024 | TMDX Transmedics Group, Inc. | Director | Sell10b5-1 | 13,380 | $83.63 | $1,118,954.54 | -5.7% | +64.9% | -7.7% | |
| Nov 28, 2023 | TMDX Transmedics Group, Inc. | Director | Sell | 10,000 | $70.14 | $701,400.00 | -4.1% | +10.6% | +23.9% | |
| Feb 23, 2023 | TMDX Transmedics Group, Inc. | Director | Sell | 10,000 | $75.13 | $751,300.00 | -3.9% | -8.0% | +6.9% | |
| Jul 29, 2022 | TMDX Transmedics Group, Inc. | Director | Sell | 48,515 | $39.98 | $1,939,629.70 | -16.1% | +18.9% | +126.1% | |
| Jul 5, 2022 | TMDX Transmedics Group, Inc. | Director | Sell | 48,515 | $35.00 | $1,698,025.00 | -13.8% | +20.1% | +132.7% | |
| May 4, 2022 | TMDX Transmedics Group, Inc. | Director | Sell | 48,516 | $29.94 | $1,452,569.04 | -12.2% | +21.5% | +139.1% |